Author

Y. Wine

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cell type annotation· 2 Organism:mouse· 2 Research Focus:cell-cell communication· 1 Assay:CITE-seq· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Barzel· 2 shared I. Benhar· 2 shared Y. Dror· 2 shared A. D. Nahmad· 1 shared A. Kigel· 1 shared A. Vaisman-Mentesh· 1 shared B. Ungar· 1 shared D. Burstein· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Barzel

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Antibody repertoire analysis of tumor-infiltrating B cells reveals distinct signatures and distributions across tissues

L. Aizik, Y. Dror, D. Taussig, A. Barzel, Y. Carmi, Y. Wine

The paper analyzes the antibody repertoire of tumor-infiltrating B cells in a mouse model of triple-negative breast cancer, finding distinct signatures and migration patterns across tissues.

bioRxiv · Mar 17, 2021Immunology

B cells engineered to express an anti-HIV antibody allow memory retention, class switch recombination and clonal selection in mice

A. D. Nahmad, Y. Raviv, M. Horovitz-Fried, I. Sofer, T. Akriv, D. Nataf, I. Dotan, D. Burstein, Y. Wine, I. Benhar, A. Barzel

This study shows engineered B cells expressing anti-HIV antibodies can persist in mice, undergo class switch recombination, and show clonal selection after immunization.

bioRxiv · Feb 28, 2020Immunology

Molecular Landscape of Anti-Drug Antibodies Reveals the Mechanism of the Immune Response Following Treatment with TNF-alpha Antagonists

A. Vaisman-Mentesh, S. Rosenstein, M. Yavzori, Y. Dror, E. Fudim, B. Ungar, U. Kopylov, O. Picard, A. Kigel, S. Ben-Horin, I. Benhar, Y. Wine

The paper identifies the molecular features of anti-drug antibodies (ADA) against TNF-alpha antagonists and reveals their formation mechanism through a new bio-immunoassay.

bioRxiv · Dec 11, 2019Immunology